Cargando…
New strategies for cancer immunotherapy: targeting regulatory T cells
The immunosuppressive action of regulatory T (T(reg)) cells is one mechanism attributed to the limited success of cancer immunotherapies with checkpoint blockers. Two recent studies report distinct transcriptional profiles of tumor-infiltrating T(reg) cells and expression of specific molecules, sugg...
Autores principales: | Finotello, Francesca, Trajanoski, Zlatko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5273791/ https://www.ncbi.nlm.nih.gov/pubmed/28129791 http://dx.doi.org/10.1186/s13073-017-0402-8 |
Ejemplares similares
-
Neoantigens Generated by Individual Mutations and Their Role in Cancer Immunity and Immunotherapy
por: Efremova, Mirjana, et al.
Publicado: (2017) -
Quantifying tumor-infiltrating immune cells from transcriptomics data
por: Finotello, Francesca, et al.
Publicado: (2018) -
TIminer: NGS data mining pipeline for cancer immunology and immunotherapy
por: Tappeiner, Elias, et al.
Publicado: (2017) -
Targeting FMRP: A new window for cancer immunotherapy
por: Zhang, Yaguang, et al.
Publicado: (2023) -
Targeting PCSK9: a promising adjuvant strategy in cancer immunotherapy
por: Almeida, Catarina R., et al.
Publicado: (2021)